SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,471 | -23.0% | 976,938 | +1.5% | 0.00% | – |
| Q2 2023 | $799,072 | +158.9% | 962,738 | +37.2% | 0.00% | – |
| Q1 2023 | $308,697 | -25.4% | 701,584 | 0.0% | 0.00% | – |
| Q4 2022 | $413,864 | -15.7% | 701,584 | +0.1% | 0.00% | – |
| Q3 2022 | $491,000 | -53.1% | 701,003 | -2.9% | 0.00% | – |
| Q2 2022 | $1,046,000 | -61.4% | 721,651 | +0.1% | 0.00% | – |
| Q1 2022 | $2,712,000 | -49.2% | 721,151 | +5.6% | 0.00% | – |
| Q4 2021 | $5,334,000 | – | 682,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 78,115 | $294,000 | 0.05% |
| Shaolin Capital Management LLC | 275,000 | $1,034,000 | 0.03% |
| Spectrum Management Group, LLC | 5,030 | $19,000 | 0.00% |
| Veritable, L.P. | 43,551 | $164,000 | 0.00% |
| ALPS ADVISORS INC | 45,083 | $170,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 13,187 | $34,000 | 0.00% |
| Qube Research & Technologies Ltd | 24,179 | $91,000 | 0.00% |
| NORTHERN TRUST CORP | 44,476 | $167,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 301,110 | $1,132,000 | 0.00% |